Department of Orthopaedics, University of Iowa, Iowa City, Iowa.
J Arthroplasty. 2017 Dec;32(12):3675-3679. doi: 10.1016/j.arth.2017.08.010. Epub 2017 Aug 31.
The purpose of this study is to answer the following questions: (1) What is the prevalence of opioid use prior to primary total hip arthroplasty (THA)? (2) What is the typical trend in opioid use following THA over the first post-operative year? (3) What are the risk factors for prolonged opioid use following primary THA?
Primary THA patients were identified in the Humana database from 2007 to 2015. Pre-operative and post-operative opioid use was measured by monthly prescription refill rates. Rates of opioid use were trended monthly for 1 year post-operatively and compared based on pre-operative opioid user (OU) status as well as other patient demographics and co-morbidities.
In total, 37,393 THA patients were analyzed and 14,309 patients (38.2%) were pre-operative opioid users (OUs). Pre-operative opioid use was the strongest predictor for prolonged opioid use following THA, with non-opioid users filling significantly less opioid prescriptions than OUs at every time point analyzed. Younger age, female sex, and all other diagnoses analyzed were found to significantly increase the rate of opioid refilling following THA throughout the entire post-operative year.
Over one-third of THA patients use opioids within 3 months prior to THA and this percentage has increased 6% during the years included in this study. Pre-operative opioid use was most predictive of increased refills of opioids following THA. These data provide an important baseline for opioid use trends following THA that can be used for future comparison while identifying risk factors for prolonged use that will be helpful to prescribers as we all work to decrease opioid use, misuse, and abuse.
本研究旨在回答以下问题:(1)初次全髋关节置换术(THA)前阿片类药物使用的流行率是多少?(2)THA 后第一年阿片类药物使用的典型趋势是什么?(3)初次 THA 后长期使用阿片类药物的风险因素有哪些?
在 2007 年至 2015 年期间,在 Humana 数据库中确定了初次 THA 患者。通过每月的处方补充率来衡量术前和术后的阿片类药物使用情况。对术后 1 年内的阿片类药物使用情况按月进行趋势分析,并根据术前阿片类药物使用者(OU)状态以及其他患者人口统计学和合并症进行比较。
共分析了 37393 例 THA 患者,其中 14309 例(38.2%)患者术前为阿片类药物使用者(OUs)。术前阿片类药物使用是 THA 后长期使用阿片类药物的最强预测因素,非阿片类药物使用者在分析的每个时间点都比 OUs 开的阿片类药物处方明显减少。研究发现,年龄较小、女性和所有其他分析的诊断在整个术后一年内显著增加了 THA 后阿片类药物补充的几率。
超过三分之一的 THA 患者在 THA 前 3 个月内使用阿片类药物,而在本研究纳入的年份中,这一比例增加了 6%。术前阿片类药物使用是 THA 后阿片类药物补充增加的最主要预测因素。这些数据为 THA 后阿片类药物使用趋势提供了重要的基线,可用于未来的比较,同时确定长期使用的风险因素,这将有助于医生减少阿片类药物的使用、误用和滥用。